Back to Search
Start Over
Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.
- Source :
-
Critical care (London, England) [Crit Care] 2020 Jul 19; Vol. 24 (1), pp. 446. Date of Electronic Publication: 2020 Jul 19. - Publication Year :
- 2020
- Subjects :
- Aged
COVID-19
Female
Humans
Male
Middle Aged
Pandemics
Prospective Studies
Treatment Outcome
Coronavirus Infections complications
Coronavirus Infections drug therapy
Neuromuscular Blocking Agents therapeutic use
Pneumonia, Viral complications
Pneumonia, Viral drug therapy
Respiratory Distress Syndrome drug therapy
Respiratory Distress Syndrome virology
Subjects
Details
- Language :
- English
- ISSN :
- 1466-609X
- Volume :
- 24
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Critical care (London, England)
- Publication Type :
- Report
- Accession number :
- 32684169
- Full Text :
- https://doi.org/10.1186/s13054-020-03164-2